Status:
COMPLETED
EMERALD - AssEssment of CoMorbidities & Atrial ArRhythmiA Burden in DuaL-Chamber PaceD Patients
Lead Sponsor:
MicroPort CRM
Conditions:
Atrial Arrhythmia
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to evaluate the incidence and evolution over-time of co-morbidities in a general dual-chamber pacemaker population (n=2188 patients) through a 2 years follow-up.
Detailed Description
The study will focus on the number of patients moving to persistent Atrial Fibrillation as a function of cumulative %Vp (\< or \>40%), in a general dual-chamber pacemaker population through a 2 year f...
Eligibility Criteria
Inclusion
- \- Patient implanted (primo-implant, replacement, upgrade) with dual chamber pacemaker from less than two months or implanted at inclusion.
Exclusion
- Contraindicated for cardiac pacing, according to the ESC and ACC/AHA/HRS guidelines
- Permanent or persistent atrial tachyarrhythmia
Key Trial Info
Start Date :
March 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 31 2017
Estimated Enrollment :
4350 Patients enrolled
Trial Details
Trial ID
NCT01188356
Start Date
March 1 2010
End Date
August 31 2017
Last Update
March 25 2019
Active Locations (190)
Enter a location and click search to find clinical trials sorted by distance.
1
Southwest Cardiovascular Associates
Mesa, Arizona, United States, 85205
2
Mountain Vista Medical Center
Mesa, Arizona, United States, 85209-3767
3
Pacific Arrhythmia Services
Mesa, Arizona, United States, 91942
4
Peoria, Arizona, United States